← Insider buys
BMRN

BioMarin Pharmaceutical Inc. · Healthcare

CEO Jean Jacques Bienaime sold $360K of BioMarin Pharmaceutical Inc.

Sold$359,560
$89.89Price
4,000Shares
−1%Stake

What BMRN did after the filing

Prices for BMRN after this filing aren't in yet.

Traded Fri, Oct 14. Filed Tue, Oct 18, 8:01 PM ET, after the close. Not investment advice.